Management Group  

The Management Group consists of the Director, Chief Executive Officer and remaining 3 founding members of the Centre. 

Download Organisational Chart (pdf 745kB)

The Director is Professor Villis Marshall, AC
An internationally recognized consultant specialist, educator and researcher in urology. Professor Marshall is currently appointed as Clinical Director of Surgical and Specialities Service, Royal Adelaide Hospital and Strategic Clinical Director of Acute Services, Central Northern Adelaide Health Service. He Chairs the Executive Committee of the Australian Prostate Cancer Collaboration. He has been awarded Companion of the Order of Australia (AC) for service to medicine in urology and kidney disease research. He was also awarded the Bailiff Grand Cross of the Order of St John of Jerusalem, the Order’s highest award. Professor Marshall currently holds 14 memberships of learned societies, has published over 300 articles and has received over 50 research grants.

The Chief Executive Officer is Ms Anne Hayes 
Ms Hayes has a Masters in Public Health from the University of North Carolina at Chapel Hill and is an internationally experienced public health practitioner.  During her 15 year public health career she has held a range of policy, program and research related positions in the USA, New Zealand, Sweden, Singapore and Australia.  She has extensive experience in health policy development and analysis, strategic and program planning, training and communications, research and evaluation, relationship management and project management. 

The other founding members are:

Professor Gary Wittert
Currently Mortlock Professor of Medicine, and Head of the School of Medicine at the University of Adelaide, Senior Consultant Endocrinologist at the Royal Adelaide Hospital, and a member of the Hanson Research Institute. He is a past president of the Australasian Society for the Study of Obesity, and is currently vice president of the Asia Oceania Association of the Study of Obesity. He is the lead investigator on the Florey Adelaide Male Aging Study (FAMAS), and is also an investigator in the North West Adelaide Obesity and Lifestyle and Environment (NOBLE) Study, and the Men in Australia, Telephone Survey (MATeS). He is also the principle investigator of a number of clinical trials of novel drugs to treat obesity and type 2 diabetes mellitus. Prof Wittert has authored over one hundred peer-reviewed papers and book chapters, and is a founding Editor in Chief of the "Journal of Obesity Research and Clinical Practice".

Professor Wayne Tilley
Chair of the Dame Roma Mitchell Cancer Research Laboratories and Head of the Cancer Research Centre at the Hanson Institute. Through his NHMRC CJ Martin Fellowship at UT Southwestern in Dallas, Texas, he was one of the first to clone the human androgen receptor (AR), which is the key cellular mediator of the effects of testicular androgens. Since then, Prof Tilley’s laboratory has made a major contribution to understanding the molecular mechanisms of resistance to conventional hormonal (androgen ablation) therapies used in the treatment of prostate cancer. Prof. Tilley was a Director of the Australian Society for Medical Research (1984-1987; 1991-1993), being President in 1993. Prof Tilley is a Board member of Andrology Australia and currently chair of the Research Advisory Committee of the National Breast Cancer Foundation. Prof Tilley has published more than 100 publications, and his research has been presented at numerous international meetings.

Professor Richard Ivell
Head of the School of Molecular and Biomedical Science at the University of Adelaide. As an Alexander-von-Humboldt fellow, and academic faculty member of the University of Hamburg, he undertook pioneering work into the synthesis and control of neurohormones in the brain, and in particular of what subsequently became referred to as the "love hormone", oxytocin. He later became director of the Institute for Hormone and Fertility Research at the University of Hamburg, where he introduced the power of the molecular sciences to understanding reproductive physiology in both males and females. He has published more than 250 scientific articles, including numerous reviews and three books. Until recently, he was also Editor-in-Chief of the leading international scientific journal Molecular Human Reproduction, stepping down following two full terms of office.